MedTrace Logo

Evaluation of Colecalciferol Substitution in Dialysis Patients

NCT00397475 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-05-27

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of a colecalciferol substitution in dialysis patients on bone metabolism and immune system

Conditions

  • RENAL INSUFFICIENCY, CHRONIC
  • Hyperparathyroidism, Secondary

Interventions

DRUG

Colecalciferol

Sponsors & Collaborators

  • University Hospital, Saarland

    lead OTHER

Principal Investigators

  • Eric Seibert, M.D. · University Hospital of Saarland, Dpt. of Internal Medicine IV, Div. of Nephrology and Hypertension

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Completion
2007-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00397475 on ClinicalTrials.gov